Cas:5351-07-5 2-(4-Methoxyphenyl)-2-methylpropanenitrile manufacturer & supplier

Chemical Name:2-(4-Methoxyphenyl)-2-methylpropanenitrile

CAS.NO:5351-07-5

Synonyms:2-(4-Methoxy-phenyl)-2-methyl-propionitril;2-(4-methoxy-phenyl)-2-methyl-propionitrile;2-(p-anisyl)-2-methylpropionitrile;2-(4-methoxyphenyl)2-methylpropanenitrile;2-(4-METHOXY-PHENYL)-2-METHYL-PROPIONITRILE;2-Methyl-2-(4-methoxy-phenyl)-propionsaeure-nitril

Molecular Formula:C₁₁H₁₃NO

Molecular Weight:175.22700

HS Code:2926909090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:284.9ºC at 760mmHg

Density:1.009g/cm3

Index of Refraction:1.502

PSA:33.02000

Exact Mass:175.10000

LogP:2.49638

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-(4-Methoxy-phenyl)-2-methyl-propionitril chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Methyl-2-(4-methoxy-phenyl)-propionsaeure-nitril physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(p-anisyl)-2-methylpropionitrile Use and application,2-(4-methoxy-phenyl)-2-methyl-propionitrile technical grade,usp/ep/jp grade.

Related News: The government will also send a charter flight with an Air New Zealand crew to repatriate up to 300 citizens in Wuhan. 2-(4-Methoxyphenyl)-2-methylpropanenitrile manufacturer Two sources familiar with the situation told Reuters that the agency had cleared about 10 million doses. 2-(4-Methoxyphenyl)-2-methylpropanenitrile supplier In a memo to Branchburg employees on May 20, Nellie Clark, head of the plant, summed up the outside lawyers’ findings: “In the end and very importantly, allegations that Lilly made false statements to the FDA were not substantiated.” 2-(4-Methoxyphenyl)-2-methylpropanenitrile vendor In a memo to Branchburg employees on May 20, Nellie Clark, head of the plant, summed up the outside lawyers’ findings: “In the end and very importantly, allegations that Lilly made false statements to the FDA were not substantiated.” 2-(4-Methoxyphenyl)-2-methylpropanenitrile factory In a memo to Branchburg employees on May 20, Nellie Clark, head of the plant, summed up the outside lawyers’ findings: “In the end and very importantly, allegations that Lilly made false statements to the FDA were not substantiated.”